020 7407 3100

General News

Medtronic Linq

08 June 2015

City of London Medical Centre is proud to be able to provide a range of services for the diagnosis and treatment of numerous cardiac conditions, offering appointments which are convenient for busy City professionals.

The City of London Medical Centre has launched a new service in the last six months – the implantable Medtronic Linq device. This device can help diagnose patients experiencing infrequent palpitations, Atrial Fibrillation (AF), ‘funny turns’, blackouts or syncope.

The device is the smallest implantable heart monitor in the world (the size of two matchsticks), and replaces the older Reveal XT monitor, which was the size of a memory stick. This device is able to continuously record a single-lead ECG for up to three years. It automatically detects episodes of profound bradycardia, tachycardia or AF, and transmits these wirelessly to a secure website. The device is used to diagnose causes of palpitations or syncope, to detect AF or to confirm success after treatments such as catheter ablation. The device is safe for use in MRI scanners.

The Medtronic Linq is injected under local anaesthetic via a small incision in the lower left chest using an implant tool, which takes less than a minute. Unlike the old device, this new tiny monitor can be implanted in a procedure room as an outpatient procedure and the device is not visible. Once inserted, the new device communicates wirelessly to its home port, called a ‘MyCareLink’ monitor.

The ‘MyCareLink’ monitor will work anywhere in the world where there is a 3G mobile phone network, so patients can still be monitored on holiday or if travelling abroad on business. If abnormal heart rhythm data is detected, it is transmitted from the Medtronic Linq to the MyCareLink monitor automatically every night over a secure internet connection. Automatic transmissions simply require the patient to be within 2m of the monitor. The information transmitted is accessible only by the Consultant, via a secure web portal – and serious events, such as profound tachycardia or bradycardia, will generate an email alert to the Consultant 24 hours a day, 7 days a week. Patients can also send information at other times, for example if they are experiencing symptoms, using the monitor’s digital display, which guides the transmission process and confirms information has been sent correctly.

This device has been available at London Bridge Hospital for some time, but is now available in an outpatient setting, meaning patients do not have to travel to the main hospital, but can have the device implanted at a convenient time for them, such as during a lunch break or after work.

Visit medtronicdiagnostics.com to learn more about the device.

Visit the City of London Medical Centre website.

Consultant profile – Dr Oliver Segal